Work

Supplementary Table 2 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer

Year: 2023
Type: supplementary-materials
Abstract: PDF file, 136K, Median IC50's for NSCLC cell lines (with ganetespib and 17-AAG) with different genotypic subtypes.
Language: English
Open Access status: gold
OpenAlex ID: W4362461341
Cites:
Cited by:
Related to: 10